SHEPHERD Therapeutics Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • SHEPHERD Therapeutics's estimated annual revenue is currently $2.3M per year.(i)
  • SHEPHERD Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • SHEPHERD Therapeutics has 15 Employees.(i)
  • SHEPHERD Therapeutics grew their employee count by -17% last year.

SHEPHERD Therapeutics's People

NameTitleEmail/Phone
1
founder, patient & ceoReveal Email/Phone
2
co-founder & advisory chairmanReveal Email/Phone
3
Founder and CEOReveal Email/Phone
4
Chief Business OfficerReveal Email/Phone
5
Chief Research OfficerReveal Email/Phone
6
Chief Strategy OfficerReveal Email/Phone
7
chief research officerReveal Email/Phone
8
Director Patient Advocacy and EngagementReveal Email/Phone
9
Senior ScientistReveal Email/Phone
10
Computational EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is SHEPHERD Therapeutics?

SHEPHERD’s mission is to cure rare cancers. We work closely with rare-cancer specific disease foundations to identify and pursue the highest potential translational science. We then leverage those relationships to run clinical trials which are finely attuned to the specific needs of rare cancer patients. Our platform-agnostic approach allows us to select the most technologically innovative solutions for patients and to diversify our portfolio of lead compounds across rare cancers, therapeutic platforms, and partnership and licensing structures. SHEPHERD aims to be the development partner of choice for other biopharma companies looking to expand the application of therapeutic platforms and approaches into rare and orphan indications, but which encounter P&L and other business limitations preventing them from doing so. To learn more, visit shepherd.bio. BioSpace's Top 20 Companies to Watch in 2018 Forbes 30 Under 30

keywords:N/A

N/A

Total Funding

15

Number of Employees

$2.3M

Revenue (est)

-17%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.5M15-40%N/A
#2
$2.3M15N/AN/A
#3
$0.9M15N/AN/A
#4
$1.3M15N/AN/A
#5
$1M157%N/A